Return to Trial Database

BTCRC-LUN20-462

A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab
as Second Line Treatment for Small Cell Lung Cancer

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-LUN20-462 being conducted in.

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

The Ohio State University

University of Illinois Cancer Center

University of Iowa Holden Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center